This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Sagimet Biosciences Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Anne-Marie O’Farrell: Inventor in Metabolic and Liver Disorder Research.
Introduction
Anne-Marie O’Farrell is an inventor associated with Burlingame, California. Her patent work concerns therapeutic combinations intended to address metabolic and liver disorders.
Latest Patents
O’Farrell is named on 1 patent: “Combination Therapies of FASN Inhibitors with Thyroid Hormone Receptor Agonists.” The patent describes combinations of fatty acid synthesis modulators and thyroid hormone receptor agonists that may be used to treat disorders, including nonalcoholic steatohepatitis and metabolic dysfunction-associated steatohepatitis, also known as NASH/MASH.
Career Highlights
O’Farrell is associated with Sagimet Biosciences Inc. Her listed patent reflects research into combining therapeutic approaches that target fatty acid synthesis and thyroid hormone receptor activity.
Collaborations
Her listed coworkers include George Kemble and Wen-Wei Tsai.
Conclusion
Anne-Marie O’Farrell’s patent work focuses on potential combination therapies for metabolic and liver disorders, including NASH/MASH.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile